SignatureFD
PCRX icon

SignatureFD’s Pacira BioSciences PCRX Stock Holding History

SignatureFD’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.3K Buy
690
+489
+243% +$12.4K ﹤0.01% 2487
2026
Q2 		$5.1K Buy
201
+74
+58% +$1.75K ﹤0.01% 2857
2026
Q1 		$2.87K Sell
127
-20
-14% -$444 ﹤0.01% 2954
2025
Q4 		$3.8K Hold
147
– – ﹤0.01% 2786
2025
Q3 		$3.79K Buy
147
+6
+4% +$147 ﹤0.01% 2770
2025
Q2 		$3.37K Hold
141
– – ﹤0.01% 2720
2025
Q1 		$3.5K Hold
141
– – ﹤0.01% 2716
2024
Q4 		$2.66K Buy
141
+56
+66% +$983 ﹤0.01% 2784
2024
Q3 		$1.28K Sell
85
-12
-12% -$205 ﹤0.01% 2949
2024
Q2 		$2.78K Sell
97
-257
-73% -$7.32K ﹤0.01% 2673
2024
Q1 		$10.3K Buy
354
+7
+2% +$215 ﹤0.01% 2284
2023
Q4 		$11.7K Buy
347
+313
+921% +$9.16K ﹤0.01% 2191
2023
Q3 		$1.04K Sell
34
-20
-37% -$721 ﹤0.01% 2931
2023
Q2 		$2.16K Sell
54
-450
-89% -$18.6K ﹤0.01% 2781
2023
Q1 		$20.6K Buy
504
+439
+675% +$17.5K ﹤0.01% 1856
2022
Q4 		$2.51K Sell
65
-17
-21% -$827 ﹤0.01% 2728
2022
Q3 		$4K Buy
82
+18
+28% +$1K ﹤0.01% 2549
2022
Q2 		$4K Buy
64
+33
+106% +$2.16K ﹤0.01% 2532
2022
Q1 		$2K Hold
31
– – ﹤0.01% 2837
2021
Q4 		$2K Hold
31
– – ﹤0.01% 2768
2021
Q3 		$2K Hold
31
– – ﹤0.01% 2688
2021
Q2 		$2K Hold
31
– – ﹤0.01% 2606
2021
Q1 		$2K Hold
31
– – ﹤0.01% 2510
2020
Q4 		$2K Sell
31
-8
-21% -$468 ﹤0.01% 2293
2020
Q3 		$2K Buy
39
+8
+26% +$465 ﹤0.01% 2259
2020
Q2 		$2K Buy
+31
New +$1.3K ﹤0.01% 2164

Other funds holding PCRX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return
GA
Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SignatureFD's PCRX Position: Q3 2026 in Review

SignatureFD increased its Pacira BioSciences (PCRX) stake by 243% in Q3 2026, buying an estimated $12.4K and bringing the position to 690 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2487.

SignatureFD first reported a position in PCRX in Q2 2020 and has held it in 26 quarters since. The position peaked at $20.6K in Q1 2023. 115 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • SignatureFD held 690 shares of Pacira BioSciences worth $17.3K as of Q3 2026.
  • SignatureFD bought 489 Pacira BioSciences shares in Q3 2026, an estimated $12.4K.
  • Pacira BioSciences made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2487 holding.
  • SignatureFD first reported a position in Pacira BioSciences in Q2 2020 and has held it in 26 quarters since.
  • SignatureFD's Pacira BioSciences position peaked at $20.6K in Q1 2023.
  • 115 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.